LYT-300
Anxiety disorders
Phase 1Active
Key Facts
About PureTech Health
PureTech Health is a Boston-based biotech studio that creates and funds separate companies around innovative scientific discoveries, de-risking development and capturing value through equity and royalties. Its model has proven exceptionally successful, boasting a 6x higher clinical success rate than the industry average and delivering three FDA-approved therapies. The company's strategy leverages a deep network of academic collaborators and seasoned leadership to build a diversified portfolio across immunology, neurology, and gastroenterology.
View full company profileOther Anxiety disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Anxiety Clinical Trials | Boston Clinical Trials | Not Specified (Typically Phase 2-3) |
| GABA-A PAM for Anxiety | Modulate Bio | Discovery |
| Anxiety Disorders Biomarker Services | The Siesta Group | Service Offering |
| Supera-CBD | TNF Pharmaceuticals | Preclinical |
| TLR-007 | Tilray | Phase 1/2 |
| CTx-2103 | Cingulate | Preclinical |